Chronic kidney disease trials in Brazil

In Brazil 24 Also abroad 798

24 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Barretos, Belém, Brasília, Campina Grande do Sul, Campinas, Curitiba, Fortaleza, Joinville, Natal, Porto Alegre, Rio de Janeiro, São José do Rio Preto, São Paulo
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Aracaju, Belém, Belo Horizonte, Blumenau, Bragança Paulista, Brasília, Campinas, Campo Grande, Canoas, Curitiba, Fortaleza, Jaú, Marília, Niterói, Porto Alegre, Rio de Janeiro, Salvador, São Bernardo do Campo, São José do Rio Preto, São José dos Campos, São Paulo, Tatuí, Vitória, Votuporanga
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseNot yet taking people in Brazil
Combined Versus Multicomponent Training in People With Chronic Kidney Disease Stages 3a and 3b
Where
Brasília
Age
55 years to 70 years
People
57
Run by
University of Brasilia
See details and how to joinNCT07901621
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Curitiba, Florianópolis, Porto Alegre, São Paulo
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
No phaseTaking people
The Solaris DE Sirolimus-Eluting Covered Stent for the Treatment of AV Access Stenosis or Occlusion
Where
Belo Horizonte, Brasília, Recife, Rio de Janeiro, Salvador
Age
18 years and over
People
160
Run by
Scitech Produtos Medicos SA
See details and how to joinNCT06096142
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Belo Horizonte, Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Curitiba, Ribeirão Preto, São Paulo
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Barretos, Belém, Belo Horizonte, Campinas, Goiânia, Natal, Recife, São Caetano do Sul, São José do Rio Preto, São José dos Campos, São Paulo
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Belo Horizonte, Fortaleza, Goiânia, Joinville, Maringá, Natal, Passo Fundo, Porto Alegre, Praia Do Canto, Ribeirão Preto, Salvador, São José do Rio Preto, São Paulo
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 1Not yet taking people in Brazil
Pharmacokinetics of Zoledronic Acid in Patients on Dialysis
Where
Campinas
Age
18 years and over
People
24
Run by
University of Campinas, Brazil
See details and how to joinNCT07741136
No phaseTaking people
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Where
Bragança Paulista, Brasília, Campina Grande do Sul, Colatina, Curitiba, Fortaleza, Goiânia, Joinville, Poços de Caldas, Salvador, Santa Cruz do Sul, São Caetano do Sul, São Paulo, Teresina
Age
18 years and over
People
35,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT03549754
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Barretos, Belém, Belo Horizonte, Bragança Paulista, Brasília, Campina Grande do Sul, Campinas, Curitiba, Joinville, Natal, Porto Alegre, Presidente Prudente, São José dos Campos, São Paulo
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
No phaseTaking people
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
Where
Barro Preto, Campina Grande, Ponta Grossa, Porto Alegre, São Paulo, Ubá
Age
18 years and over
People
3,600 worldwide
Run by
The University of Queensland
See details and how to joinNCT03573089
No phaseNot yet taking people in Brazil
Multi-Site STARgraft (10401) Trial
Where
Brasília, Florianópolis, Recife, Rio de Janeiro, Salvador
Age
18 years and over
People
111 worldwide
Run by
Healionics Corporation
See details and how to joinNCT07557862
No phaseTaking people
BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS
Where
Araçatuba, Belo Horizonte, Botucatu, Curitiba, Goiânia, Rio de Janeiro, Santa Maria, Santo André, São Paulo
Age
18 years and over
People
743
Run by
Hospital Alemão Oswaldo Cruz
See details and how to joinNCT07118683
No phaseTaking people
Red Propolis Supplementation as a Strategy in Chronic Kidney Disease
Where
Rio de Janeiro
Age
18 years to 65 years
People
40
Run by
Universidade Federal Fluminense
See details and how to joinNCT07597005
No phaseTaking people
Effects of Royal Jelly Supplementation in Chronic Kidney Disease
Where
Rio de Janeiro
Age
18 years to 70 years
People
30
Run by
Universidade Federal Fluminense
See details and how to joinNCT06438445
No phaseTaking people
Beetroot Extract Supplementation Associated With an Exercise Protocol for Chronic Kidney Disease Patients
Where
Rio de Janeiro
Age
18 years to 65 years
People
25
Run by
Universidade Federal Fluminense
See details and how to joinNCT06286748
No phaseTaking people
Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease
Where
Rio de Janeiro
Age
18 years to 75 years
People
153
Run by
Universidade Federal Fluminense
See details and how to joinNCT06288204
No phaseNot yet taking people in Brazil
Effects of Jaboticaba (Plinia Cauliflora) Supplementation in Chronic Kidney Disease Patients
Where
Rio de Janeiro
Age
18 years to 75 years
People
30
Run by
Universidade Federal Fluminense
See details and how to joinNCT06394531
No phaseEnrolling by invitation
Physical Exercise and Biomolecular Analysis to Reduce Uremic Toxins in Chronic Kidney Disease: An Exploratory Study
Where
Taguatinga
Age
18 years and over
People
1,600
Run by
Catholic University of Brasília
See details and how to joinNCT06910475
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Curitiba, Porto Alegre, São Paulo
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
Phase 4Taking people
Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
Where
Bragança Paulista, Brasília, Campo Grande, Ponta Grossa, Salvador, São Paulo
Age
18 years and over
People
1,500
Run by
Hospital Sirio-Libanes
See details and how to joinNCT06402851
No phaseEnrolling by invitation
Clinical Outcomes of Hemodialysis in Brazil (COHEBRA): a Prospective Cohort Study
Where
Pelotas
Age
18 years and over
People
500
Run by
Catholic University of Pelotas
See details and how to joinNCT05273424